105 related articles for article (PubMed ID: 1880730)
1. Enhancement of dissolution and absorption of mefenamic acid by egg albumin.
Imai T; Nohdomi K; Acartürk F; Otagiri M
J Pharm Sci; 1991 May; 80(5):484-7. PubMed ID: 1880730
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.
Kojima T; Higashi K; Suzuki T; Tomono K; Moribe K; Yamamoto K
Pharm Res; 2012 Oct; 29(10):2777-91. PubMed ID: 22219167
[TBL] [Abstract][Full Text] [Related]
3. [Biopharmaceutical evaluation of the rectal application of mefenamic acid. I. Study of the suppositories prepared on hydrophilic bases].
Kosiar A
Acta Pol Pharm; 1983; 40(1):105-9. PubMed ID: 6880815
[No Abstract] [Full Text] [Related]
4. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
Owusu-Ababio G; Ebube NK; Reams R; Habib M
Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
Andrews GP; Zhai H; Tipping S; Jones DS
J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
[TBL] [Abstract][Full Text] [Related]
6. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
Fine-Shamir N; Dahan A
Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
[TBL] [Abstract][Full Text] [Related]
7. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
8. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. II. Analysis of suppositories prepared on lipophilic bases].
Kosior A
Acta Pol Pharm; 1984; 41(5):565-9. PubMed ID: 6532137
[No Abstract] [Full Text] [Related]
9. In Vitro and In Vivo Evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions.
Bani-Jaber A; Alshawabkeh I; Abdullah S; Hamdan I; Ardakani A; Habash M
AAPS PharmSciTech; 2017 Jul; 18(5):1750-1759. PubMed ID: 27752935
[TBL] [Abstract][Full Text] [Related]
10. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
Kosior A
Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
[No Abstract] [Full Text] [Related]
11. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. IV. Biological availability of mefenamic acid on the base of polyoxyethylene glycol with the addition of polysorbates].
Kosior A
Acta Pol Pharm; 1987; 44(1):91-5. PubMed ID: 3673627
[No Abstract] [Full Text] [Related]
12. Some physicochemical properties of mefenamic acid.
Adam A; Schrimpl L; Schmidt PC
Drug Dev Ind Pharm; 2000 May; 26(5):477-87. PubMed ID: 10789059
[TBL] [Abstract][Full Text] [Related]
13. Preparation and investigation of mefenamic acid - polyethylene glycol - sucrose ester solid dispersions.
Fülöp I; Gyéresi Á; Kiss L; Deli MA; Croitoru MD; Szabó-Révész P; Aigner Z
Acta Pharm; 2015 Dec; 65(4):453-62. PubMed ID: 26677901
[TBL] [Abstract][Full Text] [Related]
14. Enhancement effect of lauric acid on the rectal absorption of propranolol from suppository in rats.
Ogiso T; Iwaki M; Kashitani Y; Yamashita K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2657-61. PubMed ID: 1806286
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
16. Effect of glycyrrhizinate on dissolution behavior and rectal absorption of amphotericin B in rabbits.
Tanaka M; Takahashi M; Kuwahara E; Koyama O; Ohkubo K; Yotsuyanagi T
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1559-62. PubMed ID: 1394677
[TBL] [Abstract][Full Text] [Related]
17. Effects of food on absorption of mefenamic acid from two commercial capsules differing in bioavailability under the fasting state.
Hamaguchi T; Shinkuma D; Yamanaka Y; Mizuno N
J Pharmacobiodyn; 1987 Jan; 10(1):21-5. PubMed ID: 3585692
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and diuretic effect of bumetanide following rectal administration of suppositories containing weak acids in human subjects.
Yagi N; Kenmotsu H; Shimode Y; Oda K; Sekikawa H; Takada M
Biol Pharm Bull; 1993 Nov; 16(11):1124-9. PubMed ID: 8312869
[TBL] [Abstract][Full Text] [Related]
19. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
